Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 59 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 13 Drug Therapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 Antineoplastic Agents 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × anifrolumab × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡